Common Contracts
2 similar 364-Day Bridge Credit Agreement contracts by Takeda Pharmaceutical Co LTD
AMENDMENT NO. 1 Dated as of June 8, 2018 to 364-DAY BRIDGE CREDIT AGREEMENT Dated as of May 8, 2018364-Day Bridge Credit Agreement • December 6th, 2018 • Takeda Pharmaceutical Co LTD • Pharmaceutical preparations • New York
THIS AMENDMENT NO. 1 (this “Amendment”) is made as of June 8, 2018 by and among Takeda Pharmaceutical Company Limited, a joint-stock company organized and existing under the laws of Japan, (the “Company”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the “Administrative Agent”), under that certain 364-Day Bridge Credit Agreement dated as of May 8, 2018 by and among the Company, the Lenders and the Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings given to them in the Credit Agreement.
AMENDMENT NO. 1 Dated as of June 8, 2018 to 364-DAY BRIDGE CREDIT AGREEMENT Dated as of May 8, 2018364-Day Bridge Credit Agreement • September 11th, 2018 • Takeda Pharmaceutical Co LTD • New York
THIS AMENDMENT NO. 1 (this “Amendment”) is made as of June 8, 2018 by and among Takeda Pharmaceutical Company Limited, a joint-stock company organized and existing under the laws of Japan, (the “Company”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the “Administrative Agent”), under that certain 364-Day Bridge Credit Agreement dated as of May 8, 2018 by and among the Company, the Lenders and the Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings given to them in the Credit Agreement.
